Small-molecule inhibitors of PD-1/PD-L1 immune checkpoint alleviate the PD-L1-induced exhaustion of T-cells
Łukasz Skalniak(Jagiellonian University), Tad A. Holak(Jagiellonian University)
Cited by 308
Related Papers
Immune Checkpoint PD‐1/PD‐L1: Is There Life Beyond Antibodies?
|Angewandte Chemie International Edition|2017|133
Human and mouse PD-L1: similar molecular structure, but different druggability profiles
|iScience|2020|106
Inhibitors of programmed cell death 1 (PD-1): a patent review (2010-2015)
|Expert Opinion on Therapeutic Patents|2016|104
Der Immuncheckpoint PD‐1/PD‐L1: Gibt es Therapieoptionen jenseits der Antikörper?
|Angewandte Chemie|2017|4
A PD-1/PD-L1-Sensitive Co-culture-Based Primary T-Cell Activation Assay
|Methods in molecular biology|2025|1